AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute

Circulation. 2006 May 16;113(19):2363-72. doi: 10.1161/CIRCULATIONAHA.106.174516.
No abstract available

Publication types

  • Guideline

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Anticoagulants / therapeutic use
  • Coronary Artery Disease / drug therapy
  • Coronary Artery Disease / etiology
  • Coronary Artery Disease / prevention & control*
  • Coronary Disease / drug therapy
  • Coronary Disease / etiology
  • Coronary Disease / prevention & control*
  • Diabetes Complications
  • Humans
  • Hypertension / complications
  • Influenza Vaccines
  • Lipid Metabolism
  • Renin-Angiotensin System / physiology
  • Risk Factors
  • Smoking / adverse effects

Substances

  • Adrenergic beta-Antagonists
  • Anticoagulants
  • Influenza Vaccines